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ABSTRACT
Objective: to verify the structure of factors of an instrument to measure the Heart Valve Disease Impact on Daily Life (IDCV) when 
applied to coronary artery disease patients. Method: the study included 153 coronary artery disease patients undergoing outpatient 
follow-up care. The IDCV structure of factors was initially assessed by means of confi rmatory factor analysis and, subsequently, by 
exploratory factor analysis. The Varimax rotation method was used to estimate the main components of analysis, eigenvalues greater 
than one for extraction of factors, and factor loading greater than 0.40 for selection of items. Internal consistency was estimated 
using Cronbach’s alpha coeffi cient. Results: confi rmatory factor analysis did not confi rm the original structure of factors of the IDCV. 
Exploratory factor analysis showed three dimensions, which together explained 78% of the measurement variance. Conclusion: 
future studies with expansion of case selection are necessary to confi rm the IDCV new structure of factors.
Descriptors: Validation studies; Factor Analysis; Coronary Disease; Questionnaires; Nursing.
RESUMO
Objetivo: verifi car a estrutura de fatores do Instrumento para Mensuração do Impacto da Doença no Cotidiano do Valvopata (IDCV) 
quando aplicado em coronariopatas. Método: fi zeram parte deste estudo 153 coronariopatas em seguimento ambulatorial. A 
estrutura de fatores do IDCV foi inicialmente avaliada por meio da análise confi rmatória de fatores e, subsequentemente, por meio 
da análise exploratória de fatores. Utilizou-se o método de estimação dos componentes principais de análise com rotação Varimax 
e eigenvalues acima de um para extração de fatores e carga fatorial superior a 0,40 para seleção dos itens. A consistência interna foi 
estimada por meio do coefi ciente alfa de Cronbach. Resultados: a análise confi rmatória não confi rmou a estrutura original de fatores 
do IDCV. A análise exploratória de fatores evidenciou três dimensões que, em conjunto, explicaram 78% da variância da medida. 
Conclusão: estudos futuros com ampliação da casuística são necessários para confi rmação da nova estrutura de fatores do IDCV.
Descritores: Estudos de Validação; Análise Fatorial; Doença das Coronárias; Questionários; Enfermagem.
RESUMEN
Objetivo: verifi car la estructura de factores del Instrumento para Medición del Impacto de la Enfermedad en el Cotidiano del 
Valvulópata (IDVC) aplicado a enfermos coronarios. Método: formaron parte de este estudio 153 enfermos coronarios en 
seguimiento ambulatorio. Estructura de factores del IDVC evaluada inicialmente mediante análisis confi rmatorio de factores, 
y luego por análisis exploratorio de factores. Se aplicó método de estimación de componentes principales de análisis con 
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INTRODUCTION
Coronary artery disease (CAD) is the leading cause of death 
in adults in developed countries. In the United States, CAD is 
responsible for more than half a million deaths each year(1-3). In 
Brazil in 2013, circulatory system diseases were the leading cause 
of death among diseases, corresponding to 28.0% of the number 
of deaths from defined causes that year, with acute myocardial 
infarction (AMI) being the cause of death of 85,939 individuals, 
40,366 of whom were in the Southeast region of the country(4). In 
May 2014, ischemic heart disease accounted for 11.6% of total 
hospitalizations in the Brazilian public Unified Health System(4).
Living with a chronic illness such as coronary artery dis-
ease, with the symptoms caused by it and the heart disease 
stigma results in physical, psychological and social impair-
ments, and requires regular clinical follow-up(5). 
Assuming that the impact of the disease is the result of weight-
ing between the patients’ perception of its consequences on differ-
ent dimensions of their life, and its assessment (good or bad), it is 
likely that individuals who perceive a very negative impact of the 
illness on their lives have a worse perception of quality of life(6).
The concepts quality of life and disease impact have been 
used interchangeably, i.e., most studies do not measure the 
construct “impact”, but consider the assumption that the great-
er the impact of the disease on the patient’s life, the worse 
their quality of life(7-8). 
In order to measure impact among patients with cardiac dis-
ease, Padilha et al.(6,9) built and validated an instrument that as-
sesses the impact of valvular heart disease on the daily life of 
patients. This instrument is called Heart Valve Disease Impact 
on Daily Life (IDCV). The entire IDCV presented evidence of 
internal consistency. The construct validity evaluated by means 
of factor analysis showed four factors: physical impact of the dis-
ease; impact on activities of daily living; social and emotional 
impact of the disease; and, adaptation to the disease(6).
The scope of items that make up the IDCV led to interest 
to use it on other groups of patients with heart disease. To 
this end, in the study developed by Rodrigues et al.(10), with 
expansion of cases in the study by Santos et al.(11), the IDCV 
was applied to patients with coronary heart disease. In both 
studies, the said instrument presented satisfactory evidence 
of reliability and validity. However, the convergent validity 
tested by means of correlation of its domains with generic and 
specific measures of health-related quality of life (HRQOL) 
was partially supported, with observation (not expected) of 
strong correlations between dissimilar constructs and absence 
of correlation of the domain Adaptation to the disease of the 
IDCV with the HRQOL measures.
Such results pointed to the need to reassess the structure of 
factors that led to the IDCV. In the study which presents the 
proposition of the IDCV(6), some limitations of the psychomet-
ric performance of the domain Adaptation to the disease had 
already been indicated.
Therefore, it was considered relevant to test the IDCV struc-
ture of factors when applied to patients with coronary artery 
disease. The findings of this study will contribute to the psy-
chometric refinement of the instrument built in Brazil to assess 
the impact of cardiovascular disease on patients’ lives. 
METHODS
Study type and location
This was a cross-sectional methodological study that inves-
tigated the methods of collection, organization and analysis of 
data, aimed at developing and validating research instruments 
and techniques(12). The study was carried out in the cardiology 
outpatient clinic for ischemic heart disease at a teaching hos-
pital in the state of São Paulo, Brazil.
Study participants
This study included 153 patients with coronary artery dis-
ease, aged 18 years or older, with prior clinical signs of un-
stable angina and/or myocardial infarction (MI). Patients with 
history of MI or unstable angina of less than six months, and 
those who showed inability to effectively and verbally com-
municate, were excluded.
Sampling process and sample size
The data of this study were derived from a previous study(11), 
which assessed the measurement properties of the IDCV when 
applied to patients with CAD, the sample size of which was de-
termined based on Pearson’s correlation coefficient between the 
IDCV and the domains of the Brazilian version of the MacNew 
Heart Disease Health-Related Quality of Life Questionnaire and 
the Medical Outcomes Trust Short-form Health Survey (SF36), ob-
tained based on analysis of preliminary results. Considering cor-
relation coefficients between 0.30 and 0.40, and values of α=0.05 
and beta=0.10, a sample size of 113 subjects was estimated. Con-
sidering losses, the sample size was expanded to 153. The estimat-
ed sample size met the recommendation for use of factor analysis, 
according to which the number of observations must be at least 5 
to 10 times greater than the number of variables involved(13).
Rafaela Batista dos Santos Pedrosa         E-mail: rafasantosenf@gmail.comCORRESPONDING AUTHOR
rotación Varimax y eigenvalues por sobre 1 para extracción de factores, y carga factorial superior a 0,40 para selección de 
ítems. Consistencia interna estimada mediante coeficiente alfa de Cronbach. Resultados: el análisis confirmatorio no confirmó 
la estructura original de factores del IDCV. El análisis exploratorio de factores evidenció tres dimensiones que, en conjunto, 
explicaron el 78% de la diferencia de la medida. Conclusión: estudios futuros con casuística ampliada serán necesarios para 
confirmación de la nueva estructura de factores del IDCV. 
Descriptores: Estudios de Validación; Análisis Factorial; Enfermedad Coronaria; Encuestas y Cuestionarios; Enfermería.
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Data collection
One of the researchers collected the data in a private site at 
the research location cited above. Clinical data (number of MI, 
symptoms, associated medical conditions, medications and echo-
cardiogram data) were obtained from the patient’s medical chart. 
A structured interview was used, with application of a previously 
validated instrument(14), to obtain sociodemographic data (age, 
sex, race, marital status, education, employment status and indi-
vidual and family income). Measurement of the disease impact on 
the subject’s life was measured by applying the IDCV.
Instruments
Instrument to measure the Heart Valve Disease Impact on 
Daily Life – IDCV.
The IDCV was built to evaluate the impact of valvular heart 
disease on the daily life of patients. The concept that the impact 
is a result of the disease consequences by the patient’s assess-
ment of each one of them led to the development of two groups 
of 14 items. Part A is intended to measure the degree of impact 
perceived by the patient in multiple dimensions of his or her 
life, whereas Part B was developed to consider their assessment 
(good or bad) for each of the consequences mentioned. 
In Part A, the patient responded to each of the items using 
a five-point Likert scale, ranging from 1 (strongly disagree) to 
5 (strongly agree). In Part B, a Likert scale was used for each of 
the items, with responses ranging from 1 (very bad) to 5 (very 
good). The items were grouped into four areas: Physical im-
pact of the disease – symptoms (items 11, 12 and 13); Impact 
of the disease on activities of daily living (5, 7, 9, 10 and 14); 
Social and emotional impact of the disease (items 2, 3, 4 and 
6); and, Adaptation to the disease (1 and 8). To determine the 
final score of the IDCV, all of the items were transformed in 
the same direction. Thus, all of those in Part B and items 1, 5 
and 8 of Part A, which correspond to perceptions related to 
favorable impact, were reversed. To calculate the score, each 
item corresponds to the product of the scores obtained on 
both sides of the IDCV, which can generate a minimum score 
of 1 and a maximum score of 25 for each statement evalu-
ated. The closer to 1, the lower the impact perceived by the 
subject, and the closer to 25, the greater the impact. The total 
score of the impact was calculated by the sum of all products 
obtained, with the score ranging from 14 to 350. A high score 
meant that the patient perceived negative consequences of 
the disease in their life, and these were interpreted as nega-
tive. A low score meant that the patient did not perceive the 
consequences of the disease and treatment in their life and, 
if they did, would not evaluate them as negative. Although 
this instrument was originally developed in Brazil to evalu-
ate the beliefs of patients with valvular heart disease, the set 
of statements composing it evaluates the impact of chronicity 
imposed by heart disease(6).
Data analysis
Construct validity: factor analysis.
The construct validity of the IDCV was evaluated initially by 
confirmatory factor analysis by means of the SAS software PROC 
TCALIS(15). Confirmatory factor analysis is a way to test how well 
the variables measured represent a smaller number of con-
structs. Rather than allowing the statistical method to determine 
the number of factors and loadings, as in an exploratory factor 
analysis, confirmatory factor analysis statistics informs how well 
the specification of factors confirms the reality(13).
To test the adjustment of the model and verify whether the 
factors explained the correlations observed between the vari-
ables, as well as whether any of the variances of the residuals 
was equal to zero (if this occurs, the model is accepted), the 
following statistics were calculated: Chi-square test of adjust-
ment quality (checks whether the estimated covariance matrix 
is equal to the covariance matrix of the sample), which should 
present a significance level >0.05; the Goodness of Fit Index 
(GFI), with acceptance value of ≥0.85; Adjusted for Degrees 
of Freedom (AGFI), with acceptance value of ≥0.80; Bentler’s 
Comparative Fit Index (CFI) and Normed Fit Index (NFI), with 
acceptance value of  ≥0.90, and the Root mean square error of 
approximation (RMSEA), with an acceptance value of ≤0.08(16).
Subsequently, exploratory factor analysis was performed 
for identification of a new structural model, by the method 
of the main components with Varimax rotation (orthogonal 
rotation unrelated factors) and eigenvalue greater than 1. The 
eigenvalue assesses the contribution of the factor to the model 
built by factor analysis, with a value less than 1 suggesting low 
contribution of the factor in explaining the variations of the 
original variables(13).
For each item, the factor loading (saturation) on the factor 
was produced, which indicated the correlation between the 
item and the factor, so that the closer to 100% of covariance, 
the better the item was considered, since it strongly represent-
ed the latent trait measured by the factor. Therefore, descrip-
tion of the factors in terms of the items of which it is composed 
was made based on the magnitude of correlations(17). A mini-
mum factor loading = 0.40 was considered, so that the item 
could be considered representative of the factor(13,18). 
For evaluation of commonality, e.g., how much of the vari-
ance of each item was explained by each factor generated in 
the factor analysis, >0.40 was considered to be a satisfactory 
value of commonality(18). Lower commonality values suggest a 
small contribution of the item to the model built(13,16). 
Reliability
Cronbach’s alpha coefficient was used to evaluate the reli-
ability of the IDCV (total score and domains), according to the 
criterion of homogeneity of the items. The value of >0.70 
for Cronbach’s alpha coefficient was established as proof of 
internal consistency(19).
Ethical Aspects
Participants signed a free and informed consent form, and the 
study was approved by the ethics committee of the institution.
RESULTS
Descriptive analysis
Participants were predominately men (69.9%), with a mean 
age of 62.2 (SD = 10.1) years, mean study time of 4.9 (SD = 3.9) 
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years, married (66.7%), inactive (70.0%), with an individual mean 
income of 2.3 (SD = 1.9) minimum wages (MW) per month and 
mean household income of 3.8 (SD=2.8) MW per month.
Most of the patients (91.5%) had suffered MI (isolated or as-
sociated with post MI angina), with a mean of 1.2 (SD = 0.8) 
MI and 2.9 (SD=1.1) clinical conditions and/or associated 
risk factors. All patients reported having had symptoms in the 
month prior to the interview, and had a mean of 1.3 (SD=1.2) 
associated symptoms. Participants used a mean of 5.8 (SD = 
1.7) medicines per day. Based on the information available, 
the FEVE was reduced by 46.3% in 134 patients.
Construct validity
Factor analysis 
To test the structure of factors of the IDCV, confirmatory fac-
tor analysis was performed by means of the SAS software PROC 
TCALIS(13). The adequacy of the model was previously verified, 
i.e. the adequacy of correlation matrices, the results of which 
were satisfactory only for the Chi-square test of adjustment qual-
ity, the GFI and the AGFI [(c2=968.0620 {gl=77}, p<0.0001); 
NFI=0.4976; GFI=0.8717 AGFI=0.8250; CFI=0.5147 and 
RMSEA=0.2759]. 
 In the theoretical model presented (Figure 1), in which 
the factors (F1, F2, F3 and F4) are latent variables and the 
variable items observed, assumed correlation between the 
items and between factors was not observed. No item pre-
sented factor loading that permitted their insertion into more 
than one factor. 
Subsequently, exploratory factor analysis was used to iden-
tify a new structural model for the IDCV. By means of the 
estimation method of the main analysis components with Vari-
max rotation, eigenvalues greater than 1 for extraction of fac-
tors, and factor loading greater than 0.40 for selection of the 
items, four factors were obtained, which together explained 
63.0% of the variability of the measure. 
Nonetheless, the use of eigenvalues may lead to overestima-
tion of the number of factors(20), which tends to be a problem 
in large data sets, since this produces trivial factors with few 
variables(17). An alternative method recommended by experts in 
factor analysis is the scree plot, which consists of placing an ei-
genvalues graph against a number of items present(20). The num-
ber of factors is selected by observing a rupture or discontinuity 
between the higher and lower values of eigenvalues. The points 
above the discontinuity correspond to the number of factors 
of the measure. To determine where discontinuity occurred, a 
straight line was drawn through the lower values of the eigen-
values plot. The points above the straight line, i.e., above the 
discontinuity, correspond to the number of factors that explain 
the maximum variance of the measure(21).
Thus, in this study, by observation of the scree plot, the straight 
line begins to form from the number 4; above this point, only 
three factors were established that explained the higher variance 
(78.0%) of the measure of the IDCV, as shown in Figure 2.
item 11
item 12
item 13
item 5
item 7
item 9
item 10
item 14
item 2
item 3
item 4
item 6
item 2
item 3
F1
Physical impact of 
disease (symptoms)
F1
Impact of the disease on 
activities of daily living
F3
Social and emotional 
impact of the disease 
F4
Adaptation 
to the disease
Figure 1 - Original structure of factors of the instrument to 
measure the Heart Valve Disease Impact on Daily 
Life  (IDCV), proposed by Padilha et al.(9)
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Figure 2 – Scree plot of eigenvalues for the 14 items of the 
instrument to measure the Heart Valve Disease 
Impact on Daily Life (IDCV), using the main anal-
ysis component.
The factor loadings of the items in each factor and percent-
age of variance of the measure explained by each factor are 
presented in Table 1. A factor loading lower than that desired 
(<0.40) was observed only in item 13 of factor 3.
The analysis of the meaning of beliefs grouped in the fol-
lowing factors enabled the respective titles: Factor 1- Emo-
tional and social impact of the disease; Factor 2 - Physical 
impact of the disease (symptoms); and Factor 3 - Adaptation 
to the illness.
The commonality value for each of the items of the IDCV, 
which can be interpreted as the percentage of the variance 
of an original variable explained by the number of factors, is 
presented in Table 2.
Lower commonality values than desired were found in 
items 3 (My heart condition damaged my ability to work as 
before) and 13 (Because of my heart condition, I have periods 
of dizziness).
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Analysis of Reliability 
As regards the internal consistency of the items, reli-
ability was estimated by using Cronbach’s alpha coefficient 
for the factors. The contribution of each item to the total 
score and their respective dimensions/factors is presented 
in Table 3.
The data show alpha values suitable for the total IDCV and 
factors, except for the items of Factor 3 - Adaptation to the dis-
ease, which did not provide total-item correlation, generating 
an alpha value lower than desired. 
It is noteworthy that the values estimated by Cronbach’s 
alpha coefficient for the factors do not change if items are 
deleted, except for Factor 1, in which an increase in the alpha 
value (0.83 to 0.84) is shown if item 3 is deleted.
Table 1 - Factor loadings obtained by exploratory factor anal-
ysis of the instrument to measure the Heart Valve 
Disease Impact on Daily Life (IDCV) and variance 
explained by each factor (N=153), Campinas, São 
Paulo, Brazil, 2009
IDCV
Factor loading
Factor 2 Factor 2 Factor 3
Item 2: My heart condition made 
me dependent on other people. 0.61
Item 3: My heart condition damaged 
my ability to work as before. 0.54
Item 4: Today, I become more 
irritated and anxious because of 
my heart condition.
0.70
Item 6: Since I developed my heart 
condition, I feel very upset. 0.61
Item 7: After I developed my heart 
condition, I started to get scared 
that something would happen to 
me.
0.75
Item 14: Having a heart condition 
worries me. 0.75
Item 9: Because of my heart 
condition, I have difficulty 
sleeping.
0.61
Item 10: Because of my heart 
condition, I have a lot of difficulty 
performing activities of daily living.
0.67
Item 11: Because of my heart 
condition, I have a lot of shortness 
of breath.
0.76
Item 12: Because of my heart 
condition, I feel very tired. 0.76
Item 13: Because of my heart 
condition, I have periods of 
dizziness.
0.38
Item 1: After I developed my heart 
condition, I started to pay more 
attention to my health. 
0.40 0.56
Item 5: I feel okay about my heart 
condition. 0.73
Item 8: My sex life stayed the same 
as before my heart problem. 0.54
Variance explained (%) 34.0 31.0 13.0
Note: IDCV = Instrument to measure the Heart Valve Disease Impact on Daily Life
Table 2 - Commonality values obtained for the items of the 
Instrument to measure the Heart Valve Disease 
Impact on Daily Life (IDCV) (N=153), Campinas, 
São Paulo, Brazil, 2009
IDCV
Commonality
Factor 1 Factor 2 Factor 3
Item 2: My heart condition made 
me dependent on other people. 
0.42
Item 3: My heart condition 
damaged my ability to work as 
before.
0.39
Item 4: Today, I become more 
irritated and anxious because of 
my heart condition.
0.70
Item 6: Since I developed my 
heart condition, I feel very upset.
0.67
Item 7: After I developed my 
heart condition, I started to get 
scared that something would 
happen to me.
0.58
Item 14: Having a heart condition 
worries me. 
0.62
Item 9: I have difficulty sleeping 
because of my heart condition.
0.42
Item 10: Because of my heart 
condition, I have a lot of difficulty 
performing activities of daily 
living.
0.71
Item 11: Because of my heart 
condition, I have a lot of shortness 
of breath.
0.67
Item 12: Because of my heart 
condition, I feel very tired.
0.66
Item 13: Because of my heart 
condition, I have periods of 
dizziness.
0.30
Item 1: After I developed my 
heart condition, I started to pay 
more attention to my health. 
0.65
Item 5: I feel okay about my heart 
condition.
0.59
Item 8: My sex life stayed 
the same as before my heart 
condition.
0.40
Note: IDCV = Instrument to measure the Heart Valve Disease Impact on Daily Life
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DISCUSSION
This study sought to expand the psychometric performance 
evaluation of the IDCV, an instrument originally built in Brazil 
to measure the impact of disease on the daily life of patients 
with valvular heart disease, testing its structure of factors when 
applied to patients with coronary heart disease. The applica-
tion of the IDCV to patients with CAD is justified by the evi-
dence that the set of its items is relevant to measure the impact 
on patients with heart diseases with symptoms similar to that 
of valvular heart disease(10-11,22-23). 
The construct validity of the IDCV was tested by factor 
analysis. As the confirmatory analysis did not reproduce the 
factors of the original model of the IDVC proposed by Padilha 
et al.(6), exploratory analysis of factors was performed with ex-
traction method by means of analysis of the main components 
and Varimax rotation. 
Three factors were highlighted and, together, explained 78% 
of the measurement variance. Factor 1- Emotional and social 
impact of the disease, explained 34% of the measurement vari-
ance and maintained in its composition all the items (2, 3, 4 and 
6) of the domain Social and emotional impact of the disease of 
the original model of the IDCV(6), 
with addition of items 7 and 14. 
Beliefs related to both emotional 
aspects (feelings of worry, anxi-
ety, irritability/nervousness and 
fear) and ability to work and 
dependence on others, i.e., the 
social limitations imposed by the 
disease, were observed in this 
new grouping.
Factor 2 - Physical impact of 
the disease – symptoms, grouped 
the same items of the domain Im-
pact of the disease on activities 
of daily living of the prior model 
(11, 12 and 13), plus the items 
9 and 10, and explained 31% 
of the variance of the measure-
ment. This factor grouped items 
that directly measure the impact 
of symptoms, as well as beliefs re-
lated to the perception of difficul-
ties generated by the disease, for 
executing activities of daily living. 
Factor 3, consisting of items 1 
and 8 of the domain Adaptation 
to the disease from the original 
model, was added by item 5 and 
explained 12.6% of the mea-
surement variance. The beliefs 
represented in this factor seem 
to actually measure the patient’s 
adaptation to the disease. 
In this new structural model, 
the domain Impact of the dis-
ease on activities of daily living 
(5, 7, 9, 10 and 14) was deleted, 
and the items were redistributed 
into factors 1 and 2.
The reliability of the dimen-
sions generated according to 
the criterion of homogeneity 
was evaluated, as carried out 
in other studies of factor analy-
sis(24-25). The analysis indicated 
internal consistency of the new 
Table 3 –  Total-item correlation, Cronbach’s alpha and Cronbach’s alpha if item de-
leted from the factors and total score of the Instrument to measure the Heart 
Valve Disease Impact on Daily Life (IDCV) (N=153), Campinas, São Paulo, 
Brazil, 2009
Variable Total-item correlation Cronbach’s
Cronbach’s
alpha
(if item 
deleted)
Factor 1 - Emotional and social impact of the disease 0.83
Item 2: My heart condition made me dependent on 
other people. 0.52 0.83
Item 3: My heart condition damaged my ability to work as 
before. 0.48 0.84
Item 4: Today, I become more irritated and anxious 
because of my heart condition. 0.72 0.79
Item 6: I feel very upset since I developed my heart 
condition. 0.70 0.79
Item 7: After I developed my heart condition, I started 
to get scared that something would happen to me. 0.56 0.82
Item 14: Having a heart condition worries me. 0.70 0.79
Factor 2: Physical impact of the disease - Symptoms 0.80
Item 9: I have difficulty sleeping because of my heart 
condition. 0.50 0.79
Item 10: Because of my heart condition, I have a lot of 
difficulty performing activities of daily living. 0.67 0.73
Item 11: Because of my heart condition, I have a lot of 
shortness of breath. 0.64 0.74
Item 12: Because of my heart condition, I feel very tired. 0.67 0.73
Item 13: Because of my heart condition, I have periods 
of dizziness. 0.43 0.80
Factor 3: Adaptation to the disease 0.21
Item 1: After I developed my heart condition, I started to 
pay more attention to my health. 0.09 0.2
Item 5: I feel okay about my heart condition. 0.17 0.00
Item 8: My sex life stayed the same as before my heart 
condition. 0.09 0.23
IDCV - Total 0.85
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domains of the IDCV. With the exception of Factor 3, which 
had a lower-than-desired alpha (α=0.20), the other IDCV fac-
tors presented Cronbach’s alpha ≥ 0.80. 
It is notable that in the study proposing the structure of orig-
inal factors of the IDCV(6), the factor Adaptation to the disease 
presented a Cronbach’s alpha coefficient similar to that found 
in the present study (α=0.20), showing that the addition of 
item 5, suggested by the new model, did not improve the reli-
ability of the new factor. However, the alpha values estimated 
for the other factors of the new structural model and total 
score of the IDCV (α≥0.80) were greater than those observed 
in the original model (which varied between 0.68 and 0.77), 
which suggests stronger evidence of internal consistency of 
the new model of factors.
Unsatisfactory homogeneity of the three items that make 
up Factor 3 may be explained by problems in the construc-
tion of items, especially 1 and 8, as suggested by Padilha et 
al.(6). Item 1, when it affirms that the individual began to pay 
more attention to his or her health after the emergence of the 
disease, can generate an interpretation of this consequence as 
being good or bad, and this is not clear in the item. Similarly, 
in item 8, when it is specified that the sex life is the same as 
before the heart problem, the consequence of the disease as 
good or bad is probably not evaluated, because there is no 
information on quality of the sex life before the illness.
Thus, the results of this study support the idea that in the 
application of the IDCV to research the impact of disease on 
the life of the subject, items 1, 5 and 8 are considered inde-
pendent and not a factor, contributing only to the total score 
of the instrument. The maintenance of these items is indepen-
dently justified by the importance of the dimensions that rep-
resent the assessment of the impact of the disease on the sub-
ject’s life, especially attention to health and sexual function.
 A possible limitation of this study relates to its small sam-
ple size. Further studies are recommended, with expansion 
of the case material and using the factorial structure proposed 
in the present study, in order to confirm the model proposed 
and/or explore a more appropriate grouping of its items.
Specifically, the authors suggest testing the correlation of 
the new factorial structure with generic and specific measures 
of HRQOL, in order to assess the contribution of the new 
model for the validity of divergent constructs, as well as test 
its ability to discriminate the impact of the disease in groups 
with different degrees of severity of coronary heart disease. 
In short, improvement of the impact of the disease and, 
consequently, HRQOL of patients with coronary heart dis-
ease, is an important aspect of evaluating effectiveness of 
treatment(26-27). The IDCV is a reliable and valid instrument 
for assessing the impact of disease on the daily life of patients 
with valvular and coronary artery disease. It is recommended 
that further studies be conducted with a view to exploring the 
best grouping of its items, and contributing to provide a use-
ful indicator of the impact of the disease on the subject’s life.
CONCLUSION
The results of this study provide evidence that the IDCV is 
a reliable and valid instrument for assessing the impact of dis-
ease on the daily life of patients with coronary heart disease. 
Construct validity by means of factor analysis indicated that 
the grouping of items from this questionnaire can be modified 
with a view to expanding the reliability and total variance ex-
plained by the measurement. It is recommended that further 
studies with expansion of the case material be undertaken in 
order to confirm the new structural model proposed and/or 
explore a better grouping of its items.
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